Trial Profile
SWITCH Mixtard 30 NovoLet to NovoMix 30 FlexPen. An Observational Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Feb 2017
Price :
$35
*
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary) ; Insulin suspension isophane/insulin
- Indications Diabetes mellitus
- Focus Therapeutic Use
- Acronyms SWITCH
- Sponsors Novo Nordisk
- 01 Mar 2012 New trial record